Aflac stock: Mizuho lifts target but keeps Underperform rating
Published on 11/19/2026 at 12:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMizuho keeps a cautious stance
- The analyst-action table lists an Underperform rating for Mizuho.
- The broader analyst consensus remains Hold, with four Underperform ratings among 16 analysts.
On November 17, 2026, Mizuho maintained its Underperform rating on Aflac and raised its price target from 117 to 118 US dollars, according to the analyst-action table published by Aries. The change represents a modest increase in Mizuho's valuation view while leaving its cautious stance unchanged.
Analyst views remain divided
Aries lists a Hold consensus across 16 analysts, with two Buy ratings, 10 Holds and four Underperform ratings. The average 12-month price target on the page is 119.19 US dollars, below the quoted share price shown there, indicating that the analyst community remains cautious despite several higher targets.
Aflac stock traded at 113.50 euros on Lang & Schwarz at 12:38 CET on Thursday, November 19, 2026. The quote provides a current trading reference for investors following the stock in euros, while Mizuho's target is expressed in US dollars for the New York-listed shares.
What investors should watch
The latest target action keeps attention on the gap between Aflac's operating performance and the market's assessment of future earnings power. A higher target from a firm that retains an Underperform view signals that the valuation framework improved without removing concerns about the insurer's outlook.
For investors, the key issue is whether upcoming operating results can narrow the divide between bullish and cautious analyst assumptions. The rating mix and target dispersion point to a stock where expectations remain sensitive to earnings quality, capital deployment and insurance trends.
Aflac Incorporated stock
- Company: Aflac Incorporated
- ISIN: US0010551028
- Ticker: AFL
- Home exchange: NYSE
- Lang & Schwarz quote: 113.50 euros at 12:38 CET on November 19, 2026
The S&P 500 market backdrop remains relevant for the valuation of US-listed insurers.
